Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Identification of VHY/Dusp15 as a regulator of oligodendrocyte differentiation through a systematic genomics approach.

Schmidt F, van den Eijnden M, Pescini Gobert R, Saborio GP, Carboni S, Alliod C, Pouly S, Staugaitis SM, Dutta R, Trapp B, Hooft van Huijsduijnen R.

PLoS One. 2012;7(7):e40457. doi: 10.1371/journal.pone.0040457. Epub 2012 Jul 11.

2.

Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions.

Fischer I, Alliod C, Martinier N, Newcombe J, Brana C, Pouly S.

PLoS One. 2011;6(8):e23905. doi: 10.1371/journal.pone.0023905. Epub 2011 Aug 24.

3.

Chemical inducers and transcriptional markers of oligodendrocyte differentiation.

Joubert L, Foucault I, Sagot Y, Bernasconi L, Duval F, Alliod C, Frossard MJ, Pescini Gobert R, Curchod ML, Salvat C, Nichols A, Pouly S, Rommel C, Roach A, Hooft van Huijsduijnen R.

J Neurosci Res. 2010 Sep;88(12):2546-57. doi: 10.1002/jnr.22434.

PMID:
20544820
4.

Conserved regulatory sequences in Atoh7 mediate non-conserved regulatory responses in retina ontogenesis.

Skowronska-Krawczyk D, Chiodini F, Ebeling M, Alliod C, Kundzewicz A, Castro D, Ballivet M, Guillemot F, Matter-Sadzinski L, Matter JM.

Development. 2009 Nov;136(22):3767-77. doi: 10.1242/dev.033449.

5.

Live imaging of remyelination after antibody-mediated demyelination in an ex-vivo model for immune mediated CNS damage.

Harrer MD, von Büdingen HC, Stoppini L, Alliod C, Pouly S, Fischer K, Goebels N.

Exp Neurol. 2009 Apr;216(2):431-8.

PMID:
19320002
6.

Convergent functional genomics of oligodendrocyte differentiation identifies multiple autoinhibitory signaling circuits.

Gobert RP, Joubert L, Curchod ML, Salvat C, Foucault I, Jorand-Lebrun C, Lamarine M, Peixoto H, Vignaud C, Frémaux C, Jomotte T, Françon B, Alliod C, Bernasconi L, Abderrahim H, Perrin D, Bombrun A, Zanoguera F, Rommel C, Hooft van Huijsduijnen R.

Mol Cell Biol. 2009 Mar;29(6):1538-53. doi: 10.1128/MCB.01375-08. Epub 2009 Jan 12.

7.

Highly conserved sequences mediate the dynamic interplay of basic helix-loop-helix proteins regulating retinogenesis.

Hernandez J, Matter-Sadzinski L, Skowronska-Krawczyk D, Chiodini F, Alliod C, Ballivet M, Matter JM.

J Biol Chem. 2007 Dec 28;282(52):37894-905. Epub 2007 Oct 30.

8.

Beneficial effects of r-h-CLU on disease severity in different animal models of peripheral neuropathies.

Dati G, Quattrini A, Bernasconi L, Malaguti MC, Antonsson B, Nicoletti F, Alliod C, Di Marco R, Sagot Y, Vitte PA, Hiver A, Greco B, Roach A, Zaratin PF.

J Neuroimmunol. 2007 Oct;190(1-2):8-17. Epub 2007 Aug 21.

PMID:
17714795
9.

NeuroM, a neural helix-loop-helix transcription factor, defines a new transition stage in neurogenesis.

Roztocil T, Matter-Sadzinski L, Alliod C, Ballivet M, Matter JM.

Development. 1997 Sep;124(17):3263-72.

10.

Nicotinic acetylcholine receptors in the nematode Caenorhabditis elegans.

Ballivet M, Alliod C, Bertrand S, Bertrand D.

J Mol Biol. 1996 May 3;258(2):261-9.

PMID:
8627624
11.
12.

Monoclonal antibodies to the main immunogenic region of the nicotinic acetylcholine receptor bind to residues 61-76 of the alpha subunit.

Barkas T, Gabriel JM, Mauron A, Hughes GJ, Roth B, Alliod C, Tzartos SJ, Ballivet M.

J Biol Chem. 1988 Apr 25;263(12):5916-20.

13.

Genes expressed in the brain define three distinct neuronal nicotinic acetylcholine receptors.

Nef P, Oneyser C, Alliod C, Couturier S, Ballivet M.

EMBO J. 1988 Mar;7(3):595-601.

14.

Mapping the main immunogenic region and toxin-binding site of the nicotinic acetylcholine receptor.

Barkas T, Mauron A, Roth B, Alliod C, Tzartos SJ, Ballivet M.

Science. 1987 Jan 2;235(4784):77-80.

PMID:
2432658
15.

Structure linkage, and sequence of the two genes encoding the delta and gamma subunits of the nicotinic acetylcholine receptor.

Nef P, Mauron A, Stalder R, Alliod C, Ballivet M.

Proc Natl Acad Sci U S A. 1984 Dec;81(24):7975-9.

17.

A monoclonal anti-idiotypic antibody against anti-receptor antibodies from myasthenic sera.

Lefvert AK, James RW, Alliod C, Fulpius BW.

Eur J Immunol. 1982 Sep;12(9):790-2. No abstract available.

PMID:
7140816
18.

Monoclonal anti-torpedo receptor antibodies used to study antibody heterogeneity in myasthenic sera.

James RW, Lefvert AK, Alliod C, Fulpius BW.

Neurochem Int. 1982;4(1):79-84.

PMID:
20487854

Supplemental Content

Loading ...
Support Center